Norgestimate and Ethinyl Estradiol and Pegaspargase Intramuscular, Intravenous
Determining the interaction of Norgestimate and Ethinyl Estradiol and Pegaspargase Intramuscular, Intravenous and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: Theoretically, there is potential for an indirect interaction between asparaginase and oral contraceptives. The mechanism may involve asparaginase's hepatotoxicity, which may impair oral contraceptives' hepatic clearance. MANAGEMENT: The use of oral contraceptives during asparaginase treatment is not recommended. Other non-oral contraceptive methods should be used in women of childbearing potential. According to the manufacturer, females of reproductive potential should be advised to use effective contraception during asparaginase treatment and for at least 3 to 6 months after the last dose. References Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 Cerner Multum, Inc. "Australian Product Information." O 0 "Product Information. Asparlas (calaspargase pegol)." Servier, Boston, MA.
Professional:GENERALLY AVOID: Theoretically, there is potential for an indirect interaction between asparaginase and oral contraceptives. The mechanism may involve asparaginase's hepatotoxicity, which may impair oral contraceptives' hepatic clearance.
MANAGEMENT: The use of oral contraceptives during asparaginase treatment is not recommended. Other non-oral contraceptive methods should be used in women of childbearing potential. According to the manufacturer, females of reproductive potential should be advised to use effective contraception during asparaginase treatment and for at least 3 to 6 months after the last dose.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. Asparlas (calaspargase pegol)." Servier, Boston, MA.
Generic Name: ethinyl estradiol / norgestimate
Brand name: Estarylla, Femynor, Mono-Linyah, Mononessa, Ortho Tri-Cyclen, Previfem, Sprintec, Tri-Lo-Marzia, TriNessa, Ortho Tri-Cyclen, Ortho-Cyclen, Sprintec 28, Tri-Lo-Marzia>
Synonyms: Ethinyl estradiol and norgestimate, Ethinyl Estradiol and Norgestimate
Generic Name: pegaspargase
Brand name: Oncaspar
Synonyms: Pegaspargase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Norgestimate and Ethinyl Estradiol-Pegasys
- Norgestimate and Ethinyl Estradiol-Pegasys ProClick
- Norgestimate and Ethinyl Estradiol-Pegfilgrastim
- Norgestimate and Ethinyl Estradiol-Pegfilgrastim On-body Injector
- Norgestimate and Ethinyl Estradiol-Pegfilgrastim Prefilled Syringes
- Norgestimate and Ethinyl Estradiol-Pegfilgrastim Subcutaneous
- Pegaspargase Intramuscular, Intravenous-Norgestrel and Ethinyl Estradiol
- Pegaspargase Intramuscular, Intravenous-Norgestrel, ethinyl estradiol, and ferrous fumarate
- Pegaspargase Intramuscular, Intravenous-Norinyl 1+35 birth control
- Pegaspargase Intramuscular, Intravenous-Norinyl 1+50 (28)
- Pegaspargase Intramuscular, Intravenous-Noritate
- Pegaspargase Intramuscular, Intravenous-Noritate Topical